Celularity (CELU) vs Edesa Biotech (EDSA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Edesa Biotech (EDSA) has outperformed Celularity (CELU) over the past year, gaining 34.6% versus a loss of 27.9%. Over five years, EDSA leads with a -92.9% price change compared with -98.0% for CELU. Edesa Biotech is the larger company by market cap ($49.5 million vs $47.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CELU | EDSA |
|---|---|---|
| Share price | $1.46 | $3.66 |
| Market cap | $47.38M | $49.45M |
| 1-day change | -0.68% | -5.79% |
| YTD return | +32.43% | +157.75% |
| 1-year return | -27.94% | +34.56% |
| 5-year return | -97.96% | -92.88% |
| EPS (TTM) | $-2.73 | $-1.72 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.55 | $20.32 |
| 52-week low | $0.56 | $0.72 |
| Distance from 52-week high | -42.75% | -81.99% |
| Average volume | 3.89M | 62.13K |
| Shares outstanding | 32.45M | 13.51M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EDSA has outperformed CELU by 62.5 percentage points over the past year.
CELU vs EDSA FAQ
Which is bigger, Celularity or Edesa Biotech?
Edesa Biotech (EDSA) is larger, with a market capitalization of $49.45M compared with $47.38M for Celularity (CELU).
Which stock has performed better over the past year, CELU or EDSA?
EDSA returned +34.56% over the past 12 months, compared with -27.94% for CELU (price return, excluding dividends). Past performance does not predict future results.
Are Celularity and Edesa Biotech in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.